Federal Register #CMS-R-153

CMS Request for Public Comment on Information Collection Activities

CMS, part of the Department of Health and Human Services, is seeking public comment on proposed revisions to its information collection activities. - Government Buyer: - Centers for Medicare & Medicaid Services (CMS) - Department of Health and Human Services - Scope of Request: - Solicits feedback on information collection processes, not procurement of products or services - Focuses on Medicaid Drug Use Review (DUR) Program and Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals - Stakeholders: - States, pharmaceutical manufacturers, pharmacists, and other relevant parties - Notable Requirements: - Comments requested on burden estimates, necessity, utility, accuracy, and methods to improve quality and clarity of information collection - No specific OEMs or vendors mentioned - No products or services are being procured; this is a request for input to improve information collection practices

Description

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on its intention to collect information from the public under the Paperwork Reduction Act of 1995. The notice invites comments on burden estimates, necessity, utility, accuracy, and ways to enhance the quality and clarity of the information collection. The collections include revisions of currently approved collections related to Medicaid Drug Use Review (DUR) Program and Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs and Biologicals. The public comment period closes on October 20, 2026.

View original listing